Pulmonx (LUNG) EBT Margin (2019 - 2025)

Pulmonx's (LUNG) quarterly EBT Margin came in at 64.31% in Q3 2025, up 412.0% year-on-year from 12.56% in Q3 2024, and down 2.33% on a QoQ basis from 62.85% in Q2 2025.

Pulmonx (LUNG) EBT Margin (2019 - 2025) Analysis & Trends

Pulmonx (LUNG) has 7 years of EBT Margin data on file, last reported at 64.31% in Q3 2025.

  • On a quarterly basis, EBT Margin rose 412.0% year-over-year to 64.31% in Q3 2025; TTM through Sep 2025 was 61.39%, a 972.0% increase from a year earlier, with the FY2024 full-year figure at 66.71%, up 2106.0% from the prior year.
  • EBT Margin for Q3 2025 stood at 64.31%, down from 62.85% in the prior quarter.
  • Over the last five years, EBT Margin for LUNG reached as high as 55.28% in Q4 2024 and fell as low as 146.14% in Q1 2022.
  • Historically, EBT Margin has averaged 88.06% across 5 years, with a median of 84.0% in 2023.
  • On a YoY basis, EBT Margin climbed as much as 21720 bps in 2021 and fell as far as 5252 bps in 2021.
  • Year by year, EBT Margin stood at 93.77% in 2021, then increased by 3 bps to 91.0% in 2022, then gained by 22 bps to 70.75% in 2023, then grew by 22 bps to 55.28% in 2024, then dropped by 16 bps to 64.31% in 2025.
  • Per Business Quant data, the three most recent EBT Margin figures were 64.31% in Q3 2025, 62.85% in Q2 2025, and 63.51% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 12.98%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 14.12%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 18.70%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 27.84%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 22.61%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 4.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 9.84%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Pulmonx 49.94 Mn -19.81 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -64.31%
Jun 30, 2025 -62.85%
Mar 31, 2025 -63.51%
Dec 31, 2024 -55.28%
Sep 30, 2024 -68.44%
Jun 30, 2024 -73.34%
Mar 31, 2024 -71.94%
Dec 31, 2023 -70.75%
Sep 30, 2023 -84.00%
Jun 30, 2023 -93.38%
Mar 31, 2023 -108.26%
Dec 31, 2022 -91.00%
Sep 30, 2022 -104.96%
Jun 30, 2022 -104.66%
Mar 31, 2022 -146.14%
Dec 31, 2021 -93.77%
Sep 30, 2021 -76.44%
Jun 30, 2021 -105.56%
Mar 31, 2021 -134.63%
Dec 31, 2020 -94.36%